This year, gene-editing technology was customized to fix mutations in a single patient’s genes for the first time.
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...
A rare disease mom and scientist shares on the "First Opinion Podcast" how she serves as a translator between her two ...
News-Medical.Net on MSN
CRISPR-based Cellgorithm technology ushers in a new era of cell programming
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...
For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback